Репродуктивная система женщин с врожденным гипопитуитаризмом: клинические, гормонально-метаболические аспекты диагностики и комбинированной заместительной терапии
Диссертация
В этой связи исследования, направленные на изучение особенностей полового развития пациенток с врожденной соматотропной недостаточностью, а также разработка алгоритмов лечения вторичного гипогонадизма в различные возрастные периоды является весьма актуальными. Исходя из того, что до настоящего времени остается нерешенным ряд вопросов, касающихся полового развития и заместительной терапии… Читать ещё >
Содержание
- Список принятых сокращений
- Актуальность проблемы
- Цель и задачи исследования
- Научная новизна
- Практическая значимость
- Апробация работы и публикации
- Объем и структура работы
- ГЛАВА 1. Обзор литературы «Метаболические и клинические особенности вторичного гипогонадизма у женщин»
- 1. 1. Гормон роста — история вопроса
- 1. 2. Понятие, классификация и эпидемиология
- 1. 3. Структура и регуляция синтеза СТГ
- 1. 4. Взаимодйствие половых стероидов и гормона роста
- 1. 5. Состояние гипоталамо-гипофизарной области у женщин с врожденным гипопитуитаризмом
- 1. 6. Особенности липидного обмена
- 1. 7. Гормон роста и костный метаболизм
- ГЛАВА 2. Материалы и методы
- 2. 1. Клиническая характеристика обследованных больных
- 2. 1. 1. Объем и структура исследования
- 2. 1. 2. Исследование полового развития и состояния репродуктивной системы у женщин с врожденной соматотропной недостаточностью
- 2. 1. 3. Состояние гипоталамо-гипофизарной области по данным магнитно-резонансной томографии
- 2. 1. 4. Содержание липидных фракций при различных формах гипопитуитаризма и влияние заместительной гормональной терапии половыми стероидами на содержание липидов
- 2. 1. 5. Исследование минеральной плотности и минеральной массы костной ткани при различных клинических формах гипопитуитаризма
- 2. 2. Методы исследования
- 2. 2. 1. Клиническое обследование
- 2. 2. 2. Гормональные исследования. 2.2.3 Биохимические исследования
- 2. 2. 4. Рентгенологическое исследование
- 2. 2. 5. Магнитно-резонансная томография
- 2. 2. 6. Денситометрическое исследование
- 2. 2. 7. Ультразвуковое исследование
- 2. 2. 8. Цитологическое исследование
- 2. 3. Статистический анализ
- 2. 1. Клиническая характеристика обследованных больных
- ГЛАВА 3. Результаты исследований
- 3. 1. Половое развитие и состояние репродуктивной системы у женщин с врожденной соматотропной недостаточностью
- 3. 2. Состояние гипоталамо-гипофизарной области по данным магнитно-резонансной томографии
- 3. 3. Содержание липидных фракций при различных формах гипопитуитаризма и влияние заместительной гормональной терапии половыми стероидами на содержание липидов
- 3. 4. Минеральная плотность и минеральная масса костной ткани при гипопитуитаризме
- 3. 5. Клинический пример
- ГЛАВА 4. Обсуждение собственных результатов
- 4. 1. Половое развитие и состояние репродуктивной системы у женщин с врожденной соматотропной недостаточностью
- 4. 2. Состояние гипоталамо-гипофизарной области по данным магнитно-резонансной томографии
- 4. 3. Содержание липидных фракций при различных формах гипопитуитаризма и влияние заместительной гормональной терапии половыми стероидами на содержание липидов
- 4. 4. Минеральная плотность и минеральная масса костной ткани при гипопитуитаризме
- Выводы
Список литературы
- Волеводз H.H. Состояние соматотропной функции гипофиза у детей с гипофизарным нанизмом и идиопатической низкорослостью. Автореф. дисс. к.м.н. М., 1996, 24 с.
- Дедов И.И., Семичева Т. В., Петеркова В. А. Половое развитие детей: норма и патология, Москва, «Колорит студио», 2002.
- Дедов И.И., Тюльпаков А. Н., Петеркова В. А. Соматотропная недостаточность, Москва, «ИндексПринт», 1998.
- Дедов И.И., Вакс В. В., Марова Е. И. Диагностика и лечение приобретенной недостаточности гормона роста у взрослых. Методическое пособие для врачей, Москва, 2001.
- Йен C.C.K.// Репродуктивная эндокринология. 2 т. Москва, «Медицина», 1998.
- Нагаева Е.В.// Клинические, гормональные и метаболические проявления соматотропной недостаточности у взрослых карликов на фоне заместительной терапии гормоном роста автореф. дисс. к.м.н., 2002.
- Риггс Б.Л., Мелтон III. Л. // Остеопороз. Этиология, диагностика, лечение. Санкт-Петербург, «Невский диалект». 2000.
- Риггс Б.Л. Остеопороз. Этиология, диагностика, лечение. М., Бином. -2000.
- Рожинская Л.Я.// Системный остеопороз. М., издатель Мокеев, 2000.
- Стандартные принципы обследования и лечение детей и подростков с гинекологическими заболеваниями и нарушениями полового развития// под ред. Кулакова В. И., Уварвой Е. В., М., Триада-Х, 2004.
- П.Фофанова О.В.// Клинический полиморфизм и молекулярно-генетическая гетергенность соматотропной недостаточности у детей. -автореф. дисс. д.м.н. 1999-
- Abdu Т., Neary R., Elhadd Т. et al.// Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. J Clin Endocrinol (Oxf). 2001 Aug, 55(2): 209−216.
- Argyropoulou M., Perignon F., Brauner R. et al.// Magnetic resonance imaging in the diagnosis of growth hormone deficiency. J Pediatr. 1992 Jun-120(6):886−91.
- Attie K. The importance of growth hormone replacement therapy for bone mass in young adults with growth hormone deficiency. J Pediatr Endocrinol Metab. 2000 Sep, 13: 1011−1021.
- Angelin B, Rudling M. Growth hormone and hepatic lipoprotein metabolism. Current Opinion In Lipidology 5(3): 160−5, 1994 Jun.
- Angelin В., Rubling M. Growth hormone and hepatic lipoprotein metabolism. Current Opinion In Lipidology 1994, 5: 160−165.
- Attanasio AF., Lamberts SWJ., Matranga AMC., et al.// «Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment». J Clin Endocrinol Metab, 1997 82:82−88.
- Attanasio AF., Lamberts SWJ., Matranga AMC., et al.// Adults growth hormonedeficient patients demonstrate heterogenity between childhood on-adults on- before and during human GH treatment. J Clin Endocrinol 82: 82−88,1997.
- Attanasio A., Lamberts S., Matranga A. et al.// Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab. 1997, 82(1): 82−88.
- Barkan A.// The «quality of life-assessment of growth hormone deficiency in adults» questionnaire: can it be used to assess quality of life in hypopituitarism? JCE&M 2001 May- 86(5): 1905−7.
- Barnard R., Quirk P., Waters MJ. et al.// Characterization of the growth hormone-binding protein of human serum using a panel of monoclonal antibodies. J Endocrinol. 1989 Nov- 123(2):327−32.
- Baroncelli G.I., Ceccarelli C.// Measurement of Volumetric Bone Mineral Density Accurately Determines Degree of Lumbar Undermineralization in Children with Growth Hormone Deficiency. JCE&M Vol. 83, No. 9 31 503 154.
- Baumann G., Maheshwari H. The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. Acta Paediatr (Suppl). 1997 Nov, 423: 33−38.
- Bengtsson B., Abs R., Bennmarker H., Monson J. et al.// The effects of treatment and the individual responsiveness to growth hormone (GH)replacement therapy in 665 GH-deficient adults. J Clin Endocrinol Metab. 1999, 84(11): 3929−3935.
- Bennani-Baiti I.M., Cooke N.E.// Physical linkage of the human growth hormone gene cluster and the CD79b (Ig beta/B29) gene. Genomics, March 1, 1998- 48(2): 258−64.
- Bennani-Baiti I.M., Jones B.K., Liebhaber S.A. et al.// Physical linkage of the human growth hormone gene cluster and the skeletal muscle sodium channel alpha-subunit gene (SCN4A) on chromosome 17. Genomics. 1995 Oct 10- 29(3)-647−52.
- Beshyah S.A., Henderson A., Niththyananthan R. et al.// The effects of short and long-term growth hormone replacement therapy in hipopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab 80:356−363,1995.
- Bex M., Abs R., Maiter D.// The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial. J Bone Miner Res. 2002 Jun- 17(6): 1081−94.
- Binnerts A., Swart G., Wilson J. et al.// The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as body composition. J Clin Endocrinol. 1992, 37: 79−87.
- Boer H., Blok G.J., Voerman H.J. et al.// Serum levels in growth hormone-deficient men. Metab Clin Exp. 43:199−203, 1994.
- Bouillon R. Growth hormone and bone/ Horm Res 1991 (Suppl), 36: 49−55.
- Burman P., Johansson A.G., Siegbahn A. et al.// Growth hormone (GH) -deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 1997 Feb, 82(2): 550−5.
- Bulow B., Hagmar L., Mikoczy Z. et al.// Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol (Oxf). 1997, 46:75−81.
- Cacciari E., Zucchini S., Ambrosetto P. // Empty sella in children and adolescents with possible hypothalamic-pituitary disorders. J Clin Endocrinol Metab. 1994 Mar- 78(3):767−71.
- Canalis E., Lian JB.// Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone. 1988- 9(4):243−6.
- Capaldo B., Patti L., Oliviero U. et al.// Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 1997 May, 82(5): 1378−81
- Chen E.Y., Liao Y.C., Smith DH.// The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics. 1989 May- 4(4):479−97.
- Chrisoulidou A., Beshyah S., Rutherford O. et al.// Effects of 7 years of growth hormone replacement therapy in hypopituitary adults. J Clin Endocrinol Metab. 2000, 85(10): 3762−3769.
- Colao A., Marzullo P., Di Somma C. et al.// Growth hormone and the heart. Clin Endocrinol (Oxf). 2001 Feb, 54(2): 137−154.
- Colao A., di Somma C., Cuocolo A. et al.// Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab. 2001 May, 86(5): 1874−1881.
- Conceicao F., Jorgensen J., Vahl N. et al.// Evidence-based approach to growth hormone replacement therapy in adults, with special emphasis on body composition. J Pediatr Endocrinol Metab. 2000, 13 (Suppl)
- Consensus guidelines, for the diagnosis and treatment of adults with growth deficiency: summery statement of the Growth Hormone Research Society Workshop on adult growth hormone deficiency. J Clin Endocrinol Metab. 1998, 83:379−381.
- Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency// JCE&M, 1998 Vol. 83, No. 2 379−381.
- Costa A.M., Lemos-Marini S.H., Baptista M.T.// Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients. J Bone Miner Metab. 2002- 20(5):294−7.
- Cummings M.N., Christ E., Umpleby A.M. et al.// Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adults growth hormone deficiency. J Clin Endocrinol Metab 1997 Jun, 82(6) 2010−2013.
- Cuneo R.C., Salomon F., Watts G.F. et al.// Growth hormone treatment improves serum lipids and lipoproteins in adults growth hormone deficiency. Metab. Clin, Exp 42:1519−1523, 1993.
- Darendeliler F., Hindmarsh P.C., Preece M.A.// Growth hormone increases rate of pubertal maturation. Acta Endocrinol (Copenh). 1990 Mar- 122(3):414−6
- De Boer H., Blok G., van Lingen A. et al.// Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone and Mineral Res. 1994, 9(8): 1319−1326.
- Eden S., Wiklund O., Oscarsson J. et al.// Growth hormone treatment of growth hormone-deficient adults. Arterioscler Thromb. 1993 Feb- 13(2):296−301
- Elam M., Wilcox H., Saloon S. et al.// In vivo growth hormone treatment stimulates secretion of very low density lipoproteins by the perfused rat liver. J Endocrinol. 1992, 131: 2717−2722.
- Erfurth E., Bulow B., Hagmar L.// Is vascular mortality increased in hypopituitarism? Pituitary. 2000 Oct, 3(2), 77−81.
- Ezzat S., Melmed S., Endres D.// Biochemical assessment of bone (formation and resorption in acromegaly). J Clin Endocrinol Metab. 1993 Jun-76(6): 1452−7.
- Frantz A.G., Rabkin M.T.// Effects of estrogen and sex differences on secretion of human growth hormone. JCE&M. 1965, 25: 1470−1480.
- Garry P., Collins P., Devlin J.G. et al.// An open 36 monthes study of lipid change with growth hormone in adults: lipid changes following replacement growth hormone in adults acquied growth hormone deficiency. J Clin Endocrinol 134:61−66, 1996.
- Gertner J.M.// Effects of growth hormone on body fat in adults. Hormone Research 40(l-3):10−5, 1993
- Green H., Morikawa M., Nixon T.// A dual effector theory of growth-hormone action. Differentiation. 1985- 29(3): 195−8.
- Hayakawa K., Konishi Y., Matsuda T.// Development and aging of brain midline structures: assessment with MR imaging. Radiology. 1989 Jul-172(l):171−7.
- High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler Thromb 14:434−437.
- Hodis H.N., Mack W.J., Lobo R.A.// Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001 Dec 4−135(ll):939−53.
- Hodis H.N., Mack W.J., Azen S.P. et al.// NEJM, August 7, 2003- Vol. 349 (6):535−545.
- Ho K.K., Osullivan A.J., Hoffman D.M.// Metabolic actions of growth hormone in man. Endocr J 1996 Oct, 43 Suppl: S57−63
- Hu F.B., Grodstein F., Hennekens C.H.// Arch Intern Med, May 24, 1999- 159(10): 1061−6.
- Isaksson O.G., Jansson J.O., Gause I.A.// Growth hormone stimulates longitudinal bone growth directly. Science. 1982 Jun 11- 216(4551): 12 371 239
- Janssen J., van Der Toorn F., Hofland L. et al.// Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur J Endocrinol. 2001 Dec, 145(6): 711−716.
- Johansson J.O., Landin K., Tengborn L.// High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. -Arterioscler Thromb 13:290−301, 1993
- Johansson J.O., Fowelin J., Landin K. et al.// Growth hormon-deficient adults are insulin resistant. Metabolism 1995 Sep, 44(9): 1126−9,
- Johansson G., Rosen T., Lindstedt G. et al.// Effect of growth hormone treatment on body composition and cardiovascular factors in adults with growth hormone deficiency. Endocrinol J, Suppl A 3−12 1996.
- Johannsson G., Rosen T., Bengtsson B.A.// «Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults». 1997, Clin Endocrinol 47:571−581.
- Johansson A.// Gender difference in growth hormone response in adults. J Endocrinol Invest. 1999, 22 (Suppl 5): 58−60.
- Jones J., Clemmons D.// Insulin-like growth-factors and their binding proteins: biologic actions. Endocrinol Rev. 1995, 16: 3−34.
- Juul A., Bang P., Hertel N.T. // Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. JCE&M. 1994 Mar-78(3):744−52.
- Kehely A., Bates P.C., Frever P. et al.// «Short-Term Safety and Efficacy of Human GH Replacement Therapy in 595 Adults with GH Deficiency: a Comparison of two dosage Algorithms». J Clin Endocrinol Metab 2002 87 (5):1974−1979.
- Largo R.H., Prader A.// Pubertal development in Swiss girls. Helv Paediatr Acta. 1983 Aug-38(3):229−43.
- Laron Z., Sarel R., Pertzelan A.// Puberty in Laron type dwarfism. Eur J Pediatr. 1980 Jun-134(l):79−83.
- Leung K.C., Johannsson G., Leong G.M.// Estrogen regulation of growth hormone action. Endocr Rev. 2004 Oct-25(5):693−721.
- Lindsay R., Feldkamp M., Harris D.// Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr. 1994 Jul- 125(l):29−35.
- Lucidi P., Lauteri M., Lauteri S. et al.// A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults. J Clin Endocrinol Metab 1998 Feb, 83(2):353−357.
- Maghnie M., Triulzi F., Larizza D.// Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities. J Clin Endocrinol Metab. 1991 Jul-73(l):79−83.
- Marshall WA.// Sex differences at puberty. J Biosoc Sci Suppl. 1970 May- 2:31−41.
- Marwaha R., Menon P. S., Jena A.// Hypothalamo-pituitary axis by magnetic resonance imaging in isolated growth hormone deficiency patients born by normal delivery. J Clin Endocrinol Metab. 1992 Mar-74(3):654−9.
- Marzullo P., Buckway C., Pratt K.L. et al.// Colao A, Guevara-Aguirre J, Rosenfeld RG «Leptin concentrations in GH deficiency: the effect of GH insensitivity» J Clin Endocrinol Metab 2002 Feb- 87 (2): 540−5.
- McConnell E., Atkinson A., Ennis C. et al.// The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months. J Clin Endocrinol Metab. 2001. Nov., 86(11): 53 425 347.
- Mizunuma H.// Osteoporosis treatment by gynecologist.// Nippon Rinsho 2003 Feb-61(2):268−73.
- Mul D., Fredriks A.M., van Buuren S.// Pubertal development in The Netherlands 1965−1997. Pediatr Res. 2001 Oct- 50(4):479−86.
- Murray R.K., Granner D.K., Mayes P.A. et al.// Harpers biochemistry, 1988.
- Myrphy L.J., Fraisen H.G.// Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor-I expression in ovariectomised hipophysectomised rat. Endocrinology. 1988. 122:325−332.
- Nilsson A., Carlsson B., Isgaard J.// Regulation by GH of insulin-like growth factor-I mRNA expression in rat epiphyseal growth plate as studied with in-situ hybridization. J Endocrinol. 1990, 125: 67−74.
- Pellini C., di Natale B., De Angelis R.// Growth hormone deficiency in children: role of magnetic resonance imaging in assessing aetiopathogenesis and prognosis in idiopathic hypopituitarism. Eur J Pediatr. 1990 May- 149(8):536−41.
- Poehlman E.T., Toth M.J., Ades P.A.// Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest. 1997 Apr-27(4):322−6.
- Randeva H.S., Murray R.D., Lewandowski K.C. et al.// «Differential effects of GH replacements of the leptin system in GH-deficient individuals» J Clin Endocrinol Metab 2002 Feb- 87 (2): 798−804.
- Rifai N., Russell Warnich G.// Laboratory measurement of lipids, lipoproteins and apolipoproteins, 1994.
- Rosen T., Bengtsson B.A.// 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285−288.
- Rosen T., Wilhelmsen L., Landin-Wilhelmsen K. et al.// Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol. 1997 Sep, 137(3): 240−245.
- Ross J.L., Cassorla F.G., Skerda M.C.// A preliminary study of the effect of estrogen dose on growth in Turner’s syndrome. N Engl J Med. 1983 Nov 3−309(18):1104−6.
- Rosen T., Bengtsson B.A.// Premature montality due to cardiovascular disease in hypopituitarism. Lancet. 336:285−288, 1990.
- Russell-Jones D.L., Christ E., Cummings M.H. et al.// The use of stable isotopes to unravel the hyperlipidaemea of adults growth hormone deficiency. HormRes 1997, 48 Suppl 5:111−5
- Salem A., Beshyah T., Desmond G. et al.// Cardiovascular disease and risk factors in adults with hypopituitarism. Clin Endocrinol. 1999 Jan, 50(1): 1−15.
- Salomon F., Cuneo R.D., Hesp R. et al.// The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. J Clin Endocronol Metab 321:17 971 803, 1989.
- Salomon F., Cuneo R.C., Umplely A.M. et al.// Glucose and fat metabolism in adults with growth hormone deficiency. Clinical Endocrinology 41(3):315−22, 1994 Sep.
- Samuels H.H., Aranda A., Casanova J.// Identification of the cis-acting elements and trans-acting factors that mediate cell-specific and thyroid hormone stimulation of growth hormone gene expression. Recent Prog Horm Res. 1988−44:53−114.
- Scotti G., Triulzi F., Pieralli S.// Modern imaging techniques in GH secretory disorders. J Pediatr Endocrinol. 1993 Jul-Dec-6(3−4):345−56.
- Shoumer K.A., Anyaoku V., Richmond W. et al.// Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clinical Endocrinology 47(2): 153−9, 1997 Aug.
- Seidah N.G., Barale J.C., Marcinkiewicz M.// The mouse homeoprotein mLIM-3 is expressed early in cells derived from the neuroepithelium and persists in adult pituitary. DNA Cell Biol. 1994 Dec- 13(12):1163−80.
- Severi F.// Final height in children with growth hormone deficiency. -Horm Res. 1995- 43(4):138−40.
- Shoumer K.A., Gray R., Anyaoku V. et al.// Effects of four years treatmentwith biosinthetic human growth hormone (GH) on glucose homeostasis, insulinsecretion and lipid metabolism in GH-deficient adults. Clinical Endocrinology 48(6):795−802, 1998.
- Slootweg M.C., Hoogerbrugge C.M., de Poorter TL.// The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs? J Endocrinol. 1990 May-125(2):271−7.
- Smith R., Thorner M.// Human growth hormone: research and clinical practice. Humana Press. TotowaNew Jersey. 2000, 221−228.
- Sneppen S., Hoeck H., Kollerup G. et al.// Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults. An 18-month randomised, placebo-controlled, double blinded trial. Eur J of Endocrinol. 2002, 146(2): 187−195.
- Sneppen S.B., Hoeck H.C.// Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults—an 18-month randomised, placebo-controlled, double blinded trial. Eur J Endocrinol. 2002 Feb- 146(2): 187−95.
- Span J.P., Pieters G.F., Sweep C.G.II Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. JCE&M. 2000 Mar-85(3):l 121−5
- Stenlof K., Sjostrom L., Lonn L. et al.// Effects of recombinant human growth hormone on basal metabolic rate in adults with pituitary deficiency. Metabolism 1995 Jan, 44(l):67−74
- Tanalca T.// Global situation of growth hormone treatment in growth hormone- deficient children. Horm Res. 1999−51 Suppl 3:75−80.
- Tanner J.M., Davies P. S.// Clinical longitudinal standards for height and height velocity for North American children. J Pediatr. 1985 Sep-107(3):317−29
- Tomlinson J., Holden N., Hills R. et al.// Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001 Feb 10- 357 (9254): 425−431.
- Tompson R.J., Rodriguez A.// Growth hormone: metabolic clearance rate, integrated concentrations and production rates in normal adults and the effect of prednisone. 1972., J Clin Invest 51:1393 1399.
- Triulzi F., Scotti G., Natale B. et al.// Evidence of a congenital midline brain anomaly in pituitary dwarfs: a magnetic resonance imaging study in 101 patients. Pediatrics 1994, 93: 409−416.
- Vaananen H.K., Harkonen P.L.// Estrogen and bone metabolism. Maturitas 1996 May-23 Suppl: S65−9.
- Vance M., Mauras N.// Growth hormone therapy in adults and children. The New Engl J of medicine 1999 Oct, 341 (16), 1206−1216.
- Vimpani G.V., Vimpani A.F., Lidgard G.P.// Prevalence of severe growth hormone deficiency. Br Med J. 1977 Aug 13−2(6084):427−30.
- Weidemann E., Shcwartz E. // Acute and chronic estrogen effect upon serum somatomedin activity, growth hormone and prolactin in man. JCE&M 42:942−952.
- Wells G., Tugwell P., Shea B.// Endocr Rev. 2002 Aug-23(4):529−39.
- Whitehead H.M., Boreham C., Mcllrath E.M., et al. Growth hormone treatment of adults with growth hormone deficiency: results of 13 month placebo controlled cross-over study. Clin Endocrinol (Oxf) 36:45−52, 1992.
- Wilhelmsen L., Bengtsson B.A.// Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo (a) and ApoE phenotypes. Arterioscler Thromb Vase Biol 1995 Dec, 15(12):2142−50.
- Wuster C., Abs R., Bengtsson B., Bennmarker H.// The KIMS Study Group and the KIMS International Board. Pharmacia & Upjohn International Metabolic Database. The influence of growth hormone deficiency, growth